Gary Wood
Chief Scientific Officer at TVAX Biomedical, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
-
Chief Scientific Officer
-
-
-
Chairman of the Board of Directors
-
Mar 2012 - Present
TVAX Biomedical is a biotechnology company that currently is initiating a phase 2B/3 registration study of TVAX Immunotherapy as a treatment for newly diagnosed glioblastoma. TVAX Immunotherapy is a neoantigen-specific adoptive T cell therapy that exploits the ability of "killer' cells to kill cancer cells and reject progressing cancers. TVAX Biomedical is a biotechnology company that currently is initiating a phase 2B/3 registration study of TVAX Immunotherapy as a treatment for newly diagnosed glioblastoma. TVAX Immunotherapy is a neoantigen-specific adoptive T cell therapy that exploits the ability of "killer' cells to kill cancer cells and reject progressing cancers.
-
-
Education
-
University at Buffalo
Ph.D., Immunology -
University of Kansas Medical Center
Postgraduate Degree, Cancer Immunology
Community
